Annual CFO
-$30.25 M
-$30.12 M-22325.43%
December 31, 2022
Summary
- As of February 10, 2025, ACER annual cash flow from operations is -$30.25 million, with the most recent change of -$30.12 million (-22325.43%) on December 31, 2022.
- During the last 3 years, ACER annual CFO has fallen by -$745.00 thousand (-2.52%).
Performance
ACER Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFO
-$5.50 M
+$3.51 M+38.96%
June 30, 2023
Summary
- As of February 10, 2025, ACER quarterly cash flow from operations is -$5.50 million, with the most recent change of +$3.51 million (+38.96%) on June 30, 2023.
- Over the past year, ACER quarterly CFO has increased by +$4.35 million (+44.14%).
Performance
ACER Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFO
-$31.91 M
+$4.35 M+11.99%
June 30, 2023
Summary
- As of February 10, 2025, ACER TTM cash flow from operations is -$31.91 million, with the most recent change of +$4.35 million (+11.99%) on June 30, 2023.
- Over the past year, ACER TTM CFO has dropped by -$9.66 million (-43.45%).
Performance
ACER TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ACER Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10000.0% | +44.1% | -43.5% |
| 3 y3 years | -2.5% | -51.6% | -59.0% |
| 5 y5 years | -114.6% | -36.9% | -8.1% |
ACER Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | >+9999.0% | at low | +287.6% | +79.0% | >+9999.0% | +13.6% |
| 5 y | 5-year | >+9999.0% | at low | -188.2% | +79.0% | -3584.2% | +13.6% |
| alltime | all time | <-9999.0% | at low | -188.2% | +79.0% | -3584.2% | +13.6% |
Acer Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$5.50 M(-39.0%) | -$31.91 M(-12.0%) |
| Mar 2023 | - | -$9.02 M(+8.7%) | -$36.26 M(+19.8%) |
| Dec 2022 | -$30.25 M(>+9900.0%) | -$8.30 M(-8.7%) | -$30.25 M(+29.4%) |
| Sep 2022 | - | -$9.09 M(-7.8%) | -$23.37 M(+5.1%) |
| Jun 2022 | - | -$9.85 M(+227.0%) | -$22.24 M(+261.5%) |
| Mar 2022 | - | -$3.01 M(+112.2%) | -$6.15 M(+4461.3%) |
| Dec 2021 | -$134.90 K(-99.2%) | -$1.42 M(-82.2%) | -$134.90 K(-94.8%) |
| Sep 2021 | - | -$7.96 M(-227.6%) | -$2.59 M(-383.3%) |
| Jun 2021 | - | $6.24 M(+107.6%) | $915.80 K(-110.2%) |
| Mar 2021 | - | $3.00 M(-177.5%) | -$8.95 M(-47.4%) |
| Dec 2020 | -$17.03 M(-42.3%) | -$3.88 M(-12.8%) | -$17.03 M(-0.7%) |
| Sep 2020 | - | -$4.45 M(+22.5%) | -$17.14 M(-14.6%) |
| Jun 2020 | - | -$3.63 M(-28.4%) | -$20.07 M(-19.2%) |
| Mar 2020 | - | -$5.07 M(+27.0%) | -$24.83 M(-15.9%) |
| Dec 2019 | -$29.51 M(+77.9%) | -$3.99 M(-45.9%) | -$29.51 M(-2.0%) |
| Sep 2019 | - | -$7.38 M(-12.1%) | -$30.11 M(+9.6%) |
| Jun 2019 | - | -$8.39 M(-14.0%) | -$27.48 M(+18.9%) |
| Mar 2019 | - | -$9.75 M(+112.4%) | -$23.11 M(+39.3%) |
| Dec 2018 | -$16.59 M(+17.7%) | -$4.59 M(-3.4%) | -$16.59 M(+2.4%) |
| Sep 2018 | - | -$4.75 M(+18.2%) | -$16.20 M(-16.4%) |
| Jun 2018 | - | -$4.02 M(+24.6%) | -$19.39 M(+18.9%) |
| Mar 2018 | - | -$3.23 M(-23.3%) | -$16.30 M(+15.7%) |
| Dec 2017 | -$14.10 M(+53.2%) | -$4.21 M(-47.0%) | -$14.10 M(+15.4%) |
| Sep 2017 | - | -$7.93 M(+750.4%) | -$12.22 M(+85.6%) |
| Jun 2017 | - | -$933.00 K(-8.6%) | -$6.58 M(-14.3%) |
| Mar 2017 | - | -$1.02 M(-56.1%) | -$7.68 M(-16.6%) |
| Dec 2016 | -$9.20 M(-10.9%) | -$2.33 M(+1.2%) | -$9.20 M(-11.1%) |
| Sep 2016 | - | -$2.30 M(+13.4%) | -$10.36 M(-7.5%) |
| Jun 2016 | - | -$2.03 M(-20.3%) | -$11.19 M(-11.5%) |
| Mar 2016 | - | -$2.55 M(-26.9%) | -$12.65 M(+22.5%) |
| Dec 2015 | -$10.33 M(-27.3%) | -$3.48 M(+11.0%) | -$10.33 M(-2.0%) |
| Sep 2015 | - | -$3.14 M(-10.1%) | -$10.54 M(-0.6%) |
| Jun 2015 | - | -$3.49 M(+1469.7%) | -$10.60 M(+0.9%) |
| Mar 2015 | - | -$222.20 K(-94.0%) | -$10.51 M(-26.0%) |
| Dec 2014 | -$14.20 M(+131.8%) | -$3.69 M(+15.2%) | -$14.20 M(+0.3%) |
| Sep 2014 | - | -$3.20 M(-5.6%) | -$14.15 M(+2.2%) |
| Jun 2014 | - | -$3.39 M(-13.2%) | -$13.86 M(+6.0%) |
| Mar 2014 | - | -$3.91 M(+7.1%) | -$13.07 M(+113.4%) |
| Dec 2013 | -$6.13 M(-31.4%) | -$3.65 M(+25.6%) | -$6.13 M(+49.7%) |
| Sep 2013 | - | -$2.91 M(+11.3%) | -$4.09 M(+19.4%) |
| Jun 2013 | - | -$2.61 M(-185.9%) | -$3.43 M(-7.3%) |
| Mar 2013 | - | $3.04 M(-288.0%) | -$3.70 M(-58.5%) |
| Dec 2012 | -$8.92 M(+78.9%) | -$1.62 M(-27.9%) | -$8.92 M(+1.1%) |
| Sep 2012 | - | -$2.24 M(-22.2%) | -$8.83 M(+14.5%) |
| Jun 2012 | - | -$2.88 M(+31.8%) | -$7.71 M(+20.8%) |
| Mar 2012 | - | -$2.19 M(+44.0%) | -$6.38 M(+28.0%) |
| Dec 2011 | -$4.99 M | -$1.52 M(+34.9%) | -$4.99 M(+15.0%) |
| Sep 2011 | - | -$1.13 M(-27.7%) | -$4.34 M(-0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2011 | - | -$1.56 M(+96.6%) | -$4.36 M(+7.9%) |
| Mar 2011 | - | -$791.00 K(-8.9%) | -$4.04 M(-7.8%) |
| Dec 2010 | -$4.38 M(>+9900.0%) | -$868.20 K(-23.9%) | -$4.38 M(+3.7%) |
| Sep 2010 | - | -$1.14 M(-7.7%) | -$4.22 M(+421.7%) |
| Jun 2010 | - | -$1.24 M(+9.4%) | -$808.70 K(+157.1%) |
| Mar 2010 | - | -$1.13 M(+58.9%) | -$314.50 K(+3644.0%) |
| Dec 2009 | -$8400.00(-99.9%) | -$711.40 K(-131.3%) | -$8400.00(-99.6%) |
| Sep 2009 | - | $2.27 M(-405.7%) | -$2.08 M(-68.8%) |
| Jun 2009 | - | -$742.50 K(-9.9%) | -$6.67 M(-23.5%) |
| Mar 2009 | - | -$824.10 K(-70.4%) | -$8.72 M(-17.5%) |
| Dec 2008 | -$10.57 M(+14.5%) | -$2.79 M(+20.2%) | -$10.57 M(-2.7%) |
| Sep 2008 | - | -$2.32 M(-17.1%) | -$10.86 M(-6.1%) |
| Jun 2008 | - | -$2.80 M(+4.7%) | -$11.57 M(-3.2%) |
| Mar 2008 | - | -$2.67 M(-13.3%) | -$11.95 M(+29.5%) |
| Dec 2007 | -$9.23 M(-17.5%) | -$3.08 M(+1.6%) | -$9.23 M(-20.2%) |
| Sep 2007 | - | -$3.03 M(-4.8%) | -$11.57 M(+5.3%) |
| Jun 2007 | - | -$3.18 M(-6087.9%) | -$10.98 M(+11.5%) |
| Mar 2007 | - | $53.10 K(-101.0%) | -$9.85 M(-11.9%) |
| Dec 2006 | -$11.19 M(+79.9%) | -$5.41 M(+121.2%) | -$11.19 M(+50.6%) |
| Sep 2006 | - | -$2.45 M(+19.7%) | -$7.43 M(+15.7%) |
| Jun 2006 | - | -$2.04 M(+59.3%) | -$6.42 M(+14.8%) |
| Mar 2006 | - | -$1.28 M(-22.3%) | -$5.59 M(-10.1%) |
| Dec 2005 | -$6.22 M(+192.0%) | -$1.65 M(+14.8%) | -$6.22 M(+36.2%) |
| Sep 2005 | - | -$1.44 M(+18.3%) | -$4.57 M(+46.0%) |
| Jun 2005 | - | -$1.22 M(-36.3%) | -$3.13 M(+63.7%) |
| Mar 2005 | - | -$1.91 M(+8354.0%) | -$1.91 M(+2221.5%) |
| Dec 2004 | -$2.13 M(+3736.0%) | - | - |
| Mar 2004 | - | -$22.60 K(+156.8%) | -$82.30 K(+37.2%) |
| Dec 2003 | - | -$8800.00(-82.5%) | -$60.00 K(+7.9%) |
| Sep 2003 | -$55.50 K(+46.1%) | -$50.20 K(+7071.4%) | -$55.60 K(+84.1%) |
| Jun 2003 | - | -$700.00(+133.3%) | -$30.20 K(-18.2%) |
| Mar 2003 | - | -$300.00(-93.2%) | -$36.90 K(+80.0%) |
| Dec 2002 | - | -$4400.00(-82.3%) | -$20.50 K(-46.2%) |
| Sep 2002 | -$38.00 K(-77.6%) | -$24.80 K(+235.1%) | -$38.10 K(-74.3%) |
| Jun 2002 | - | -$7400.00(-146.0%) | -$148.00 K(-9.1%) |
| Mar 2002 | - | $16.10 K(-173.2%) | -$162.80 K(-4.7%) |
| Dec 2001 | - | -$22.00 K(-83.7%) | -$170.80 K(+0.9%) |
| Sep 2001 | -$169.30 K(-69.7%) | -$134.70 K(+506.8%) | -$169.30 K(-56.5%) |
| Jun 2001 | - | -$22.20 K(-374.1%) | -$389.50 K(-0.0%) |
| Mar 2001 | - | $8100.00(-139.5%) | -$389.60 K(-21.2%) |
| Dec 2000 | - | -$20.50 K(-94.2%) | -$494.30 K(-11.6%) |
| Sep 2000 | -$558.90 K(-474.6%) | -$354.90 K(+1491.5%) | -$558.90 K(-1648.2%) |
| Jun 2000 | - | -$22.30 K(-76.9%) | $36.10 K(-149.7%) |
| Mar 2000 | - | -$96.60 K(+13.5%) | -$72.70 K(-2.5%) |
| Dec 1999 | - | -$85.10 K(-135.4%) | -$74.60 K(-150.0%) |
| Sep 1999 | $149.20 K | $240.10 K(-283.1%) | $149.20 K(-264.1%) |
| Jun 1999 | - | -$131.10 K(+33.1%) | -$90.90 K(-326.1%) |
| Mar 1999 | - | -$98.50 K(-171.0%) | $40.20 K(-71.0%) |
| Dec 1998 | - | $138.70 K | $138.70 K |
FAQ
- What is Acer Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Acer Therapeutics?
- What is Acer Therapeutics annual CFO year-on-year change?
- What is Acer Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Acer Therapeutics?
- What is Acer Therapeutics quarterly CFO year-on-year change?
- What is Acer Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Acer Therapeutics?
- What is Acer Therapeutics TTM CFO year-on-year change?
What is Acer Therapeutics annual cash flow from operations?
The current annual CFO of ACER is -$30.25 M
What is the all time high annual CFO for Acer Therapeutics?
Acer Therapeutics all-time high annual cash flow from operations is $149.20 K
What is Acer Therapeutics annual CFO year-on-year change?
Over the past year, ACER annual cash flow from operations has changed by -$30.12 M (-22325.43%)
What is Acer Therapeutics quarterly cash flow from operations?
The current quarterly CFO of ACER is -$5.50 M
What is the all time high quarterly CFO for Acer Therapeutics?
Acer Therapeutics all-time high quarterly cash flow from operations is $6.24 M
What is Acer Therapeutics quarterly CFO year-on-year change?
Over the past year, ACER quarterly cash flow from operations has changed by +$4.35 M (+44.14%)
What is Acer Therapeutics TTM cash flow from operations?
The current TTM CFO of ACER is -$31.91 M
What is the all time high TTM CFO for Acer Therapeutics?
Acer Therapeutics all-time high TTM cash flow from operations is $915.80 K
What is Acer Therapeutics TTM CFO year-on-year change?
Over the past year, ACER TTM cash flow from operations has changed by -$9.66 M (-43.45%)